Why CRDM now has bag holders....
I figure since Maniactrader is bashing over at BKMP I would come bash here at CRDM... cept I will provide factual reasons why CRDM blows.
What exactly has CRDM gained FDA approval for ??
How is atrial fibrillation treated?
Several approaches are used to treat and prevent abnormal beating:
Medications are used to slow down rapid heart rate associated with AF. These treatments may include drugs such as digoxin, beta blockers (atenolol, metoprolol, propranolol), amiodarone, disopyramide, calcium antagonists (verapamil, diltiazam), sotalol, flecainide, procainamide, quinidine, propafenone, etc.
Electrical cardioversion may be used to restore normal heart rhythm with an electric shock, when medication doesn't improve symptoms.
Drugs (such as ibutilide) can sometimes restore the heart's normal rhythm. These drugs are given under medical supervision, and are delivered through an IV tube into a vein, usually in the patient's arm.
Radiofrequency ablation may be effective in some patients when medications don't work. In this procedure, thin and flexible tubes are introduced through a blood vessel and directed to the heart muscle. Then a burst of radiofrequency energy is delivered to destroy tissue that triggers abnormal electrical signals or to block abnormal electrical pathways.
Surgery can be used to disrupt electrical pathways that generate AF.
Atrial pacemakers can be implanted under the skin to regulate the heart rhythm.
Now, I'm not going to do your DD for you so go to google or Yahoo and type in "Radiofrequency ablation products". It's quite obvious it's a huge market. Not only is it a huge market but there are NUMEROUS products for that market avalible.
I highly doubt a Hospital Board or a Health care purchsing agent is going to be interested in a product that took 4 attempts to get FDA approval and is a failed NASDAQ company.
Here is a list of companies involved in this field. Boston Scientific’s EP Technologies, Medtronic, Bard Electrophysiology, Biosense Webster, Irvine Biomedical, Biotronik and Daig. Like I said it's not breakthru technology nor is it a niche market. Maybe if contracts are awarded or positive revenues are posted in a 10QSB then the company might be worth .20 a share. But until that happnes expect this to retrace a full 50% or more of it's intial run.
It took me all of 10 minutes to realize this was driven up in hype on FDA approval news and the front loaders dumped causing a 40% loss. FDA approval does not garuntee profits. This is a company in it's last breaths if you ask me.
Char
